Use of Phil Embolic Agent for Bleeding in Non-Neurological Interventions

Objective: To evaluate the safety and efficacy of the Phil liquid embolic agent in non-neurological embolization procedures. M&M: Thirty-five patients with a mean age of 62.5 years underwent percutaneous embolization using Phil for the treatment of visceral arterial bleedings in 20/35 patients (...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucatelli, Pierleone, Corona, Mario, Teodoli, Leonardo, Nardis, Piergiorgio, Cannavale, Alessandro, Rocco, Bianca, Trobiani, Claudio, Cipollari, Stefano, Zilahi de Gyurgyokai, Simone, Bezzi, Mario, Catalano, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916888/
https://www.ncbi.nlm.nih.gov/pubmed/33670124
http://dx.doi.org/10.3390/jcm10040701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916888/
https://www.ncbi.nlm.nih.gov/pubmed/33670124
http://dx.doi.org/10.3390/jcm10040701

Ejemplares similares